The role of CREM as a cAMP-mediated transcriptional regulator promises to add to the understanding of intestinal health by delineating a common mechanism of gut inflammation and repair from infectious (amebiasis) and noninfectious (Crohn’s disease and ulcerative colitis) insults. This evidence concerns the gene CREM and Crohn disease.